Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicentered Study of Exemestane and Lapatinib in Advanced Hormone-responsive Breast Cancer

NCT01005641 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT01005641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01005641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicentered Study of Exemestane and Lapatinib in Advanced Hormone-responsive Breast Cancer
Lead sponsor
National Cancer Institute, Naples
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2009
Completion date
March 31, 2012
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer